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Abstract
Multiparametric magnetic resonance imaging (mpMRI) is increasingly used in staging
early prostate cancer (PCa) but remains heavily reader-dependent. We aim to define the
incremental utility of mpMRI over clinical parameters in determining the pathologic
extracapsular extension (pECE) of PCa interpreted in a standard radiologic setting and
when further over-read by a specialized reader. We retrospectively reviewed 120 men
with clinically localized PCa undergoingmpMRI and radical prostatectomy.We obtained
radiologic prediction of pECE from standard radiologic reports (standard read) and by a
specialized reader blinded to clinical and pathologic findings (specialized read). We
determined the incremental benefit of standard read and specialized read by sequential
addition to a baseline clinical parameters-only logistic regression model predicting
pECE. The sensitivity and specificity of standard read were 77% and 44%, respectively,
whereas those of specialized read were 86% and 81%. The positive likelihood ratio was
1.7 at baseline, 1.7 adding standard read, and 6.5 adding specialized read. The negative
likelihood ratio was 0.6 at baseline, 0.5 adding standard read, and 0.1 adding specialized
read. Standard read modestly improved prediction of pECE, whereas specialized read
improved it moderately.
Patient summary: The incremental benefit of mpMRI over clinical information is small
but increases to moderate with a specialized second opinion. This second opinion may
be useful when considering active surveillance, nerve-sparing surgery, or focal therapy.
# 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.* Corresponding author. Division of Urology, Department of Surgery, DukeUniversityMedical Center,
Box 2804, Durham, NC 27710, USA. Tel. +1 919 684 5204.
.tay@duke.edu (K.J. Tay).E-mail address: kae.jackIn parallelwith aworldwide increase inprostate cancer (PCa)
incidence, there has been a surge in patient expectation to
preservepotencyandcontinencewhilepreventingmorbidity
and mortality [1,2]. On the one hand, a spectrum of gland-
sparing modalities has arisen to meet this need, particularly
in men with low-risk or low-volume intermediate-riskhttp://dx.doi.org/10.1016/j.eururo.2015.10.041
0302-2838/# 2015 European Association of Urology. Published by Elseviercancer. On the other hand, traditional whole-gland treat-
ments are reserved for appropriate candidateswith interme-
diate- and high-risk cancers. Ultimately, the optimal
management of PCa depends on accurate risk stratification
to avoid delay in intervention for those who need it and to
defer treatment in those who can be observed safely.B.V. All rights reserved.
Table 1 – Comparison of models with incremental multiparametric magnetic resonance imaging information
Sensitivity, % Specificity, % Accuracy, % LR+ LR AUC *
Clinical 60.0 63.6 61.7 1.65 0.63 0.69 (0.53–0.84)
Clinical plus MRI standard read y 68.0 59.1 63.8 1.66 0.54 0.72 (0.57–0.87)
Clinical plus MRI standard read plus MRI specialized read z 88.0 86.4 87.2 6.45 0.14 0.91 (0.82–0.99)
AUC = area under the curve; LR+ = positive [2_TD$DIFF]likelihood [3_TD$DIFF]ratio; [4_TD$DIFF]LR = [1_TD$DIFF]negative [2_TD$DIFF]likelihood [5_TD$DIFF]ratio; MRI = magnetic resonance imaging.
* Parentheses indicate 95% confidence intervals.
y Not statistically significant compared to prior model.
z Statistically significant compared to prior model.
Fig. 1 – Receiver operating characteristic (ROC) curves of all three
models. ROC curves for the clinical parameters model and each of the
subsequent models adding magnetic resonance imaging at standard
read and then specialized read.
MRI = magnetic resonance imaging; ROC = receiver operating
characteristic.
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can more accurately stage PCa compared with traditional
parameters [3,4]. Although now widely accepted and
available for PCa staging, mpMRI is expensive and
significantly affects health care costs [5,6]. The diagnostic
performance of mpMRI is affected by technical consider-
ations and heavily depends on reader experience [7]. In
situations of uncertainty, a tertiary referral sought for a
specialized review adds further cost to PCa management.
We sought to define the incremental utility of mpMRI
over clinical parameters in determining ECE when read in a
standard academic radiologic setting and when further
over-read by a dedicated reader with a special interest in
prostate mpMRI.
Our detailed methods are reported in Supplement 1. In
brief, we reviewed all men undergoing radical prostatec-
tomy for clinically localized PCa and preoperativempMRI at
our tertiary academic institution. The reference standard for
ECE was defined by pathologic examination of the
prostatectomy specimen (pECE). Radiologic prediction of
pECE was obtained from standard radiologic reports
(standard read) and by a dedicated reader with special
interest in prostate mpMRI blinded to clinical/pathologic
and standard-read findings (specialized read). We deter-
mined the incremental benefit of standard read and
specialized read in predicting pECE by sequentially adding
them to a baseline clinical parameters–only logistic
regression model trained (using bootstrapping) on a
derivation data set and applied to an independent valida-
tion data set. All analyses used a significance level of
0.05 and were generated in SAS version 9.3 (SAS Institute,
Cary, NC, USA) and R version 3.1.1 (R Foundation for
Statistical Computing, Vienna, Austria).
The total cohort included 120 men, of whom 56 (46.7%)
had pECE. Their demographic details are summarized in
Supplementary Table 1. At univariate analysis, the accuracy
(fraction of correct ECE classifications) of the mpMRI
standard read was 58.7% (area under the receiver operating
characteristic curve [AUC] = 0.60), and the accuracy of the
specialized read was 82.6% (AUC = 0.83) (Supplementary
Table 2).
The baseline clinical parameters–only logistic regression
model is detailed in Supplementary Table 3. The perfor-
mance characteristics of the baseline clinical parameters–
only model and that of the models sequentially adding
mpMRI standard read, and thenmpMRI specialized read are
shown in Table 1 and Figure 1. In general, a diagnostic test
with a likelihood ratio >10 or <0.1 has a high impact onpost-test probability, whereas a test with a likelihood ratio
of 5–10 or 0.1–0.2 is considered to have a moderate impact
[8]. The addition of the mpMRI standard read did not
significantly improve classification of pECE compared with
the first, clinical parameters–only model, culminating in a
small observed improvement in[6_TD$DIFF] the AUC (0.69 to 0.72) and
in [7_TD$DIFF]the negative likelihood ratio (0.6 to 0.5). In contrast, the
third model, which had sequential addition of the mpMRI
specialized read, significantly improved the classification of
pECE over the second model (p < 0.001). The further
specialized read led to a clinically significant improvement
in the AUC from 0.72 to 0.91, in the positive likelihood ratio
from 1.7 to 6.5, and in the negative likelihood ratio from
0.5 to 0.1. It thus appears that the observed impact of
mpMRI at standard reading was small, whereas that of a
specialized read was at least moderately significant in
influencing the post-test probability of pECE.
Contemporary mpMRI series have reported accuracy of
62–74%, sensitivity of 35–63%, and specificity of 73–91% in
the detection of ECE across a range of inclusion criteria
(Supplementary Table 4). In our series, the accuracy of
[(Fig._1)TD$FIG]
E U RO P E AN URO LOG Y 7 0 ( 2 0 1 6 ) 2 1 1 – 2 1 3 213mpMRI at standard read as a stand-alone test was at the
lower end of the spectrum, whereas the specialized read
performed exceedingly well. At closer examination, it
appears that the main difference lies overwhelmingly in
the specificity of the tests (44% vs 81%), whereas their
sensitivities were comparable (77% vs 86%). The improved
discrimination thus occurs in men who test positive with
mpMRI: Those reading ‘‘positive’’ on standard read have a
higher probability of not harboring ECE, whereas this
likelihood is reducedwith specialized read. Specialized read
may thus be valuable to men who are potent and keen for a
nerve-sparing treatment, whether radical, focal, or expec-
tant. Conversely, those who have already decided for wide
resection of periprostatic tissues based on other consider-
ations may benefit less from a specialized read.
The incremental benefit of a specialized read is congru-
ent with findings reported in contemporary literature. MRI
interpretation is highly dependent on reader experience,
with a Cohen’s Kappa as low as 0.0129 between an
experienced and inexperienced reader [7,9]. In another
learning curve study, Latchamsetty et al reported an
improvement in sensitivity from 31% to 65% and in
specificity from 65% to 71% in the detection of ECE between
their first 40 and later 40MRIs read [10]. These data support
the notion of specific training and standardized reporting
guidelines for radiologic interpretation of ECE. As interest in
nerve-sparing and gland-sparing techniques grows, a close
relationship between the urologist and radiologist and
dedicated training in prostate mpMRI interpretation for
both partners become increasingly important.
The strengths of this study are the availability of a
pathologic reference as the gold standard and the blinding
of our single specialized reader to clinical/pathologic
information. Limitations include selection bias in this
cohort of men all undergoing prostatectomy, the assump-
tion that our baseline clinical model truly simulates pre-
mpMRI physician-predictive ability, and reproducibility
given the single-reader nature of the specialized read. A
detailed discussion is offered in Supplement 2.
Clinical information remains important in predicting
ECE. There is a small benefit with mpMRI, and this benefit
becomes moderately important with a specialized read. A
specialized read may be pertinent when considering nerve-
sparing surgery or other gland-sparing approaches.
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